Amgen Important Drug Warning: Prolia® (denosumab) »

| Press Releases

This communication is to inform you of important safety information for Prolia® (denosumab). There are reports from healthcare providers of potential confusion between UDENYCA® (pegfilgrastim-cbqv) and Prolia due to carton similarities. Adverse reactions resulting from patients who received UDENYCA instead of the intended medication, Prolia, have been reported. Amgen is distributing the following Dear HCP… Read more »

Do You Think About Your Bone Health? »

| BHOF in the News, Press Releases

The National Osteoporosis Foundation Joins Organizations Worldwide to Raise Awareness and Provide Resources about Osteoporosis and Bone Health on World Osteoporosis Day, October 20th ARLINGTON, VA (October 15, 2019) In the U.S. more than 54 million people either already have osteoporosis or are at high risk of the disease due to low bone density. Osteoporosis-related… Read more »

New Report on Burden of Osteoporosis Highlights Huge and Growing Economic and Human Toll of the Disease »

| BHOF in the News, Press Releases

Approximately 2.3 Million Fractures Suffered by 2 Million on Medicare; Proven Preventive Measures Go Largely Unused ARLINGTON, VA (September 11, 2019)- A new report released today by the National Osteoporosis Foundation (NOF) finds that despite the existence of proven preventive measures, approximately 2 million Americans on Medicare suffered 2.3 million osteoporosis-related bone fractures in 2015…. Read more »

National Osteoporosis Foundation Report Finds Patient-Centered Care Is Key Element in Delivering High-Quality, High-Value Treatment »

| BHOF in the News, Press Releases

ARLINGTON, VA (July 29, 2019) — A new report released today by the National Osteoporosis Foundation (NOF), the nation’s leading  health organization dedicated to preventing osteoporosis and broken bones, found that the vast majority of patients, including those at highest risk of a osteoporotic/fragility fracture (i.e., those who have experienced a previous fracture after age… Read more »

The National Osteoporosis Foundation Launches a First of its Kind Tool to Collect Patient Input for the Osteoporosis Field »

| BHOF in the News, Press Releases

Arlington, VA (June 27, 2019) – Approximately 10 million Americans age 50 and above have osteoporosis and another 44 million have low bone density, placing them at increased risk for bone fracture. Bone fractures related to osteoporosis are responsible for more hospitalizations than heart attacks, strokes and breast cancer combined. To hear directly from patients… Read more »

National Program to Prevent and Treat Osteoporosis Launches in Houston »

| BHOF in the News, Press Releases

ARLINGTON, VA (June 17, 2019) — The National Osteoporosis Foundation is launching the Healthy Bones/Healthy Cities Initiative to provide education and patient management support for family physicians, internal medicine doctors, gynecologists, ER physicians, and advanced practice providers to help diagnose and treat osteoporosis. In the US, one in two women and one in four men… Read more »

NOF Statement in Response to Bloomberg Article 4/25/19 »

| BHOF in the News, Press Releases

Bloomberg news published an article today (4/25/19) regarding charities established by industry to support drug pricing initiatives. You can read the full article here: https://www.bloomberg.com/news/articles/2019-04-25/pharma-s-charity-allies-help-its-fight-to-keep-drug-prices-high. NOF was mentioned and quoted in the article due to our leadership of a coalition of nonprofits supporting Medicare Part D non-interference. Below is NOF’s position on this issue, which… Read more »

May is National Osteoporosis Month »

| BHOF in the News, Osteoporosis in the News, Press Releases

The National Osteoporosis Foundation (NOF) launches new resources including interactive digital tool, podcast and first-of-its-kind patient registry in honor of 35th Anniversary ARLINGTON, VA (April 22, 2019) — NOF is celebrating National Osteoporosis Month in May and its 35th Anniversary with the launch of new resources designed to help people of all ages understand the… Read more »

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture »

| Press Releases, BHOF in the News, Osteoporosis in the News

One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS,… Read more »